| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |